These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7622394)

  • 1. Coronary risk factor status after percutaneous transluminal coronary angioplasty.
    McKenna KT; Maas F; McEniery PT
    Heart Lung; 1995; 24(3):207-12. PubMed ID: 7622394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors related to functional status after percutaneous transluminal coronary angioplasty.
    Fitzgerald ST; Zlotnick C; Kolodner KB
    Heart Lung; 1996; 25(1):24-30. PubMed ID: 8775867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Normalization of lipid metabolism disturbances and clinical course after percutaneous coronary angioplasty: 6 month observation].
    Ochała A; Gabrylewicz B; Bartnik M; Garbocz P; Wycisk A; Lewicki A; Kaźmierski M; Tendera M
    Pol Arch Med Wewn; 2000 Dec; 104(6):833-41. PubMed ID: 11424662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
    JAMA; 1997 Mar; 277(9):715-21. PubMed ID: 9042843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated physical exercise capacity in smokers compared with non-smokers after coronary angioplasty despite similar luminal diameters.
    Jørgensen B; Endresen K; Forfang K; Simonsen S; Thaulow E
    Eur Heart J; 1998 May; 19(5):737-41. PubMed ID: 9717006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty.
    Posner KL; Van Norman GA; Chan V
    Anesth Analg; 1999 Sep; 89(3):553-60. PubMed ID: 10475280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results and quality of life after percutaneous transluminal coronary angioplasty: a preliminary report.
    McKenna KT; McEniery PT; Maas F; Aroney CN; Bett JH; Cameron J; Garrahy P; Holt G; Hossack KF; Murphy AL
    Cathet Cardiovasc Diagn; 1992 Oct; 27(2):89-94. PubMed ID: 1446341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial and long-term results of coronary angioplasty: a report from King Chulalongkorn Memorial Hospital.
    Ngamtrairai P; Srimahachota S; Boonyaratavej S; Udayachalerm W; Chaipromprasit C; Chayanont D; Somabutr C; Ngarmukos P
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S62-9. PubMed ID: 12188453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment and secondary prevention of coronary heart disease in general practice in Iceland.
    Sigurdsson EL; Jónsson JS; Thorgeirsson G
    Scand J Prim Health Care; 2002 Mar; 20(1):10-5. PubMed ID: 12086276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment.
    Pietersma A; Kofflard M; de Wit LE; Stijnen T; Koster JF; Serruys PW; Sluiter W
    Circulation; 1995 Mar; 91(5):1320-5. PubMed ID: 7867168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after coronary angioplasty.
    Bliley AV; Ferrans CE
    Heart Lung; 1993; 22(3):193-9. PubMed ID: 8491654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of coronary artery disease in patients receiving percutaneous transluminal coronary angioplasty: angiographic comparison of angioplasty and non-angioplasty sites.
    Ohtani R; Hiasa Y
    Intern Med; 1995 Jul; 34(7):611-7. PubMed ID: 7496068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of functional and psychological status after percutaneous transluminal coronary angioplasty.
    Tooth LR; McKenna KT; Maas F
    Heart Lung; 1999; 28(4):276-83. PubMed ID: 10409314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty.
    Gottlieb A; Banoub M; Sprung J; Levy PJ; Beven M; Mascha EJ
    J Cardiothorac Vasc Anesth; 1998 Oct; 12(5):501-6. PubMed ID: 9801967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.